Bone Marrow-Derived Vasculogenic Mesenchymal Stem Cells Enhance In Vitro Angiogenic Sprouting of Human Umbilical Vein Endothelial Cells

• Published in: International journal of molecular sciences Vol. 24; no. 1; p. 413
• Main Authors: Jang, Hyun Hee, Son, Youngsook, Park, Gabee, Park, Ki-Sook
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI 27.12.2022; MDPI AG
• Subjects: angiogenesis; bFGF; Bone Marrow; Cell Differentiation - physiology; Cells, Cultured; HGF; Human Umbilical Vein Endothelial Cells; Humans; Mesenchymal Stem Cells - metabolism; Neovascularization, Physiologic - physiology; vasculogenic mesenchymal stem cells; vasculogenic mesenchymal stem cells; HGF; angiogenesis; bFGF; bone marrow
• ISSN: 1422-0067; 1661-6596; 1422-0067
• DOI: 10.3390/ijms24010413

Vasculogenic properties of bone marrow-derived mesenchymal stem cells (MSCs) have been reported, but it is still unclear whether the vasculogenic properties are restricted to some populations of MSCs or whether the entire population of MSCs has these properties. We cultured two different populations of MSCs in different culture media and their vasculogenic properties were evaluated using In vitro spheroid sprouting assay. Neither population of MSCs expressed markers of endothelial progenitor cells (EPCs), but they were different in the profiling of angiogenic factor expression as well as vasculogenic properties. One population of MSCs expressed basic fibroblast growth factor (bFGF) and another expressed hepatocyte growth factor (HGF). MSCs expressing HGF exhibited In vitro angiogenic sprouting capacity in response to bFGF derived from other MSCs as well as to their autocrine HGF. The vasculogenic mesenchymal stem cells (vMSCs) derived from the bone marrow also enhanced In vitro angiogenic sprouting capacity of human umbilical vein endothelial cells (HUVECs) in an HGF-dependent manner. These results suggest that MSCs exhibit different vasculogenic properties, and vMSCs that are different from EPCs may contribute to neovascularization and could be a promising cellular therapy for cardiovascular diseases.